TNSN98238A1 - Macrolides nouveaux - Google Patents

Macrolides nouveaux

Info

Publication number
TNSN98238A1
TNSN98238A1 TNTNSN98238A TNSN98238A TNSN98238A1 TN SN98238 A1 TNSN98238 A1 TN SN98238A1 TN TNSN98238 A TNTNSN98238 A TN TNSN98238A TN SN98238 A TNSN98238 A TN SN98238A TN SN98238 A1 TNSN98238 A1 TN SN98238A1
Authority
TN
Tunisia
Prior art keywords
compounds
new macrolides
macrolides
new
infections
Prior art date
Application number
TNTNSN98238A
Other languages
English (en)
Inventor
Philip Dirlam John
Alastair Irvine Mcarthur Hamish
Original Assignee
Pfizer Prod Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Pfizer Prod Inc filed Critical Pfizer Prod Inc
Publication of TNSN98238A1 publication Critical patent/TNSN98238A1/fr

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07H—SUGARS; DERIVATIVES THEREOF; NUCLEOSIDES; NUCLEOTIDES; NUCLEIC ACIDS
    • C07H17/00—Compounds containing heterocyclic radicals directly attached to hetero atoms of saccharide radicals
    • C07H17/04—Heterocyclic radicals containing only oxygen as ring hetero atoms
    • C07H17/08—Hetero rings containing eight or more ring members, e.g. erythromycins
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/70—Carbohydrates; Sugars; Derivatives thereof
    • A61K31/7042—Compounds having saccharide radicals and heterocyclic rings
    • A61K31/7048—Compounds having saccharide radicals and heterocyclic rings having oxygen as a ring hetero atom, e.g. leucoglucosan, hesperidin, erythromycin, nystatin, digitoxin or digoxin
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/04—Antibacterial agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P33/00—Antiparasitic agents
    • A61P33/02—Antiprotozoals, e.g. for leishmaniasis, trichomoniasis, toxoplasmosis
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07H—SUGARS; DERIVATIVES THEREOF; NUCLEOSIDES; NUCLEOTIDES; NUCLEIC ACIDS
    • C07H1/00—Processes for the preparation of sugar derivatives
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07H—SUGARS; DERIVATIVES THEREOF; NUCLEOSIDES; NUCLEOTIDES; NUCLEIC ACIDS
    • C07H17/00—Compounds containing heterocyclic radicals directly attached to hetero atoms of saccharide radicals

Abstract

L’INVENTION CONCERNE DES COMPOSES DE FORMULE ………..DANS LAQUELLE R1, R2, R3, R4, ET Y REPRESENTENT DIVERS RADICAUX. ELLE CONCERNE EGALEMENT UN PROCEDE POUR LEUR PREPARATION AINSI QUE DES COMPOSITIONS PHARMACEUTIQUES LES CONTENANT. APPLICATION : UTILISATION DE CES COMPOSES ET COMPOSITIONS DANS LE TRAITEMENT DE DIVERSES INFECTIONS BACTERIENNES ET INFECTIONS PAR DES PROTOZOAIRES
TNTNSN98238A 1998-01-02 1998-12-30 Macrolides nouveaux TNSN98238A1 (fr)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US7034398P 1998-01-02 1998-01-02

Publications (1)

Publication Number Publication Date
TNSN98238A1 true TNSN98238A1 (fr) 2005-03-15

Family

ID=22094723

Family Applications (1)

Application Number Title Priority Date Filing Date
TNTNSN98238A TNSN98238A1 (fr) 1998-01-02 1998-12-30 Macrolides nouveaux

Country Status (34)

Country Link
US (2) US6472371B1 (fr)
EP (1) EP1044207A1 (fr)
JP (1) JP2002500230A (fr)
KR (1) KR100352809B1 (fr)
CN (1) CN1284081A (fr)
AP (1) AP9801420A0 (fr)
AR (4) AR014948A1 (fr)
AU (1) AU756409B2 (fr)
BG (1) BG104644A (fr)
BR (1) BR9814601A (fr)
CA (1) CA2316919C (fr)
CO (1) CO4970821A1 (fr)
CZ (1) CZ20002458A3 (fr)
DZ (1) DZ2698A1 (fr)
EA (1) EA200000594A1 (fr)
GT (1) GT199800206A (fr)
HR (1) HRP20000442A2 (fr)
HU (1) HUP0100420A3 (fr)
IL (1) IL137024A0 (fr)
IS (1) IS5528A (fr)
MA (1) MA24729A1 (fr)
NO (1) NO20003347L (fr)
NZ (1) NZ504986A (fr)
OA (1) OA11438A (fr)
PA (1) PA8465301A1 (fr)
PE (1) PE20000049A1 (fr)
PL (1) PL341642A1 (fr)
SK (1) SK9782000A3 (fr)
TN (1) TNSN98238A1 (fr)
TW (1) TW520374B (fr)
UY (2) UY25330A1 (fr)
WO (1) WO1999035156A1 (fr)
YU (1) YU41500A (fr)
ZA (1) ZA9811939B (fr)

Families Citing this family (37)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
AP9801420A0 (en) 1998-01-02 1998-12-31 Pfizer Prod Inc Novel macrolides.
AP1060A (en) 1998-01-02 2002-04-23 Pfizer Prod Inc Novel erythromycin derivatives.
EP1437360A3 (fr) * 1998-08-19 2005-04-06 Pfizer Products Inc. C11-carbamates des macrolides antibactériens
US6043227A (en) * 1998-08-19 2000-03-28 Pfizer Inc. C11 carbamates of macrolide antibacterials
EP1754700A3 (fr) 1999-01-27 2007-05-09 Kosan Biosciences, Inc. synthese de polycetides
CN1373767A (zh) 1999-04-16 2002-10-09 奥索-麦克尼尔药品公司 酮式大环内酯抗菌剂
US6590083B1 (en) 1999-04-16 2003-07-08 Ortho-Mcneil Pharmaceutical, Inc. Ketolide antibacterials
US6451768B1 (en) 1999-04-16 2002-09-17 Kosan Biosciences, Inc. Macrolide antiinfective agents
EA200100983A1 (ru) 1999-05-24 2002-10-31 Пфайзер Продактс Инк. Производные 13-метилэритромицина
EP1479687A4 (fr) * 2002-02-26 2006-01-04 Meiji Seika Kaisha Nouveau compose azalide cyclique a 15 chainons, nouveau derive diazalide cyclique a 16 chainons et procede de production de ceux-ci
PE20060693A1 (es) 2004-09-23 2006-09-01 Schering Plough Ltd Nuevos derivados de trifluorometansulfonanilida oxamida eter
EP1811841B1 (fr) * 2004-11-19 2009-10-28 Schering-Plough Ltd. Lutte contre des parasites chez les animaux au moyen de derives parasiticides de 2-phenyl-3-(1h-pyrrol-2-yl) acrylonitrile
DE602005019786D1 (de) * 2004-12-21 2010-04-15 Pfizer Prod Inc Makrolide
EP1890547A2 (fr) * 2005-06-09 2008-02-27 Schering-Plough Ltd. Controle de parasites chez des animaux a l'aide de derives de n-[(phenyloxy)phenyl]-1,1,1-trifluoromethanesulfonamide et de n-[(phenylsulfanyl)phenyl]-1,1,1-trifluoromethanesulfonamide
US8119667B2 (en) * 2005-12-29 2012-02-21 Schering-Plough Animal Health Corporation Carbonates of fenicol antibiotics
US20070238700A1 (en) * 2006-04-10 2007-10-11 Winzenberg Kevin N N-phenyl-1,1,1-trifluoromethanesulfonamide hydrazone derivative compounds and their usage in controlling parasites
MX2009006467A (es) * 2006-12-13 2009-08-21 Schering Plough Ltd Profarmacos solubles en agua de cloranfenicol, tiamfenicol y analogos de los mismos.
CN101605756A (zh) * 2006-12-13 2009-12-16 先灵-普劳有限公司 氟苯尼考及其类似物的水溶性前药
TWI430995B (zh) 2007-06-26 2014-03-21 Du Pont 萘異唑啉無脊椎有害動物控制劑
KR101714291B1 (ko) 2007-06-27 2017-03-08 이 아이 듀폰 디 네모아 앤드 캄파니 동물 해충 방제 방법
WO2009064953A1 (fr) * 2007-11-15 2009-05-22 Enanta Pharmaceuticals, Inc. Utilisation de dérivés de tylosine ou de macrolides pontés pour le traitement d'affections intestinales inflammatoires non spécifiques
TWI401023B (zh) 2008-02-06 2013-07-11 Du Pont 中離子農藥
KR20110038723A (ko) * 2008-07-30 2011-04-14 인터벳 인터내셔널 비.브이. 플로르페니콜에 대한 중간체로서 유용한 옥사졸린-보호된 아미노디올 화합물의 제조 방법
UA110924C2 (uk) 2009-08-05 2016-03-10 Е. І. Дю Пон Де Немур Енд Компані Мезоіонні пестициди
MX2012001646A (es) 2009-08-05 2012-03-21 Du Pont Pesticidas mesoionicos.
UA107804C2 (en) 2009-08-05 2015-02-25 Du Pont Mixtures of pesticides mezoionnyh
KR20120050467A (ko) 2009-08-05 2012-05-18 이 아이 듀폰 디 네모아 앤드 캄파니 메소이온성 살충제
PL2576523T3 (pl) 2010-05-27 2016-08-31 Du Pont Krystaliczna postać 4-[5 - [3 -chloro-5 -(trifluorometylo)fenylo] -4,5 -dihydro-5 -(trifluorometylo)-3 - izoksazolilo]-n-[2-okso-2-[(2,2,2-trifluoroetylo)amino]etylo]-1- naftalenokarboksyamidu
WO2012087630A1 (fr) 2010-12-20 2012-06-28 E.I. Du Pont De Nemours And Company Composés de pyridine et de pyrimidine utilisés pour lutter contre des nuisibles invertébrés
CA2826174A1 (fr) * 2011-01-31 2012-08-09 Meiji Seika Pharma Co., Ltd. Nouveau derive macrolide
KR20140038527A (ko) 2011-06-20 2014-03-28 이 아이 듀폰 디 네모아 앤드 캄파니 연충 감염을 치료하기 위한 복소환식 화합물
CN102260306B (zh) * 2011-07-22 2012-07-18 山东鲁抗舍里乐药业有限公司 一种制备泰拉霉素的方法
SG11201402664VA (en) 2011-11-28 2014-06-27 Du Pont N- (4 -quinolinylmethyl) sulfonamide derivatives and their use as anthelmintics
WO2013158422A1 (fr) 2012-04-17 2013-10-24 E. I. Du Pont De Nemours And Company Composés hétérocycliques pour la lutte contre des animaux nuisibles invertébrés
WO2014099837A1 (fr) 2012-12-18 2014-06-26 E. I. Du Pont De Nemours And Company Sulfonamide anti-helminthique
CN103965273B (zh) 2013-08-23 2016-05-25 普莱柯生物工程股份有限公司 一种大环内酯类化合物
CN105669798B (zh) * 2013-08-23 2019-07-26 普莱柯生物工程股份有限公司 一种大环内酯类化合物

Family Cites Families (36)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3652537A (en) * 1969-11-21 1972-03-28 Lilly Co Eli Epierythromycylamine and epierythromycyl b amine
US3923784A (en) * 1973-09-10 1975-12-02 Hoffmann La Roche Erythromycin a derivatives
YU43116B (en) * 1979-04-02 1989-04-30 Pliva Pharm & Chem Works Process for preparing 11-aza-4-o-cladinosyl-6-o-desosaminyl-15-ethyl-7,13,14-trihydroxy-3,5,7,9,12,14-hexamethyl-oxacyclopentadecane-2-one(11-aza-10-deox
US4474768A (en) * 1982-07-19 1984-10-02 Pfizer Inc. N-Methyl 11-aza-10-deoxo-10-dihydro-erytromycin A, intermediates therefor
US4585759A (en) * 1985-01-22 1986-04-29 Pfizer Inc. Antibacterial derivatives of a neutral macrolide
DE3860503D1 (de) * 1987-09-03 1990-10-04 Pliva Pharm & Chem Works 10-dihydro-10-deoxo-11-azaerythronolid-a-verbindungen,verfahren und zwischenprodukte zu ihrer herstellung und ihre verwendung in arzneimitteln und in deren herstellung.
US5141926A (en) * 1990-04-18 1992-08-25 Abbott Laboratories Erythromycin derivatives
US5824513A (en) * 1991-01-17 1998-10-20 Abbott Laboratories Recombinant DNA method for producing erythromycin analogs
WO1993013663A1 (fr) 1992-01-17 1993-07-22 Abbott Laboratories Procede permettant d'effectuer la biosynthese de polycetides specifiques
US5985844A (en) * 1992-03-26 1999-11-16 Merck & Co., Inc. Homoerythromycin A derivatives modified at the 4"-and 8A-positions
CA2065218A1 (fr) 1991-04-11 1992-10-12 Robert R. Wilkening Procede d'obtention de 9-desoxo-8a-aza-8a-homoerythromycine a et de ses derives 8a-alkyle
US5523399A (en) * 1991-12-27 1996-06-04 Taisho Pharmaceutical Co., Ltd. 5-O-desosaminylerythronolide derivatives
FR2691464B1 (fr) * 1992-05-21 1995-06-02 Roussel Uclaf Nouveaux dérivés de la 1-oxa 6-azacyclopentadécane 13,15-dione, leur procédé de préparation et leur application comme médicaments.
US5332807A (en) * 1993-04-14 1994-07-26 Merck & Co., Inc. Process of producing 8A- and 9A-azalide antibiotics
US5441939A (en) * 1994-03-04 1995-08-15 Pfizer Inc. 3"-desmethoxy derivatives of erythromycin and azithromycin
US6271255B1 (en) * 1996-07-05 2001-08-07 Biotica Technology Limited Erythromycins and process for their preparation
US6162794A (en) * 1997-05-09 2000-12-19 Pfizer Inc. Erythromycin derivatives
HN1998000086A (es) * 1997-06-11 1999-03-08 Pfizer Prod Inc Derivados de 9 - desofo - 9 aza - 9a - homoeritromicina a - c - 4 sustituidos.
US20020025937A1 (en) * 2000-03-20 2002-02-28 Yong-Jin Wu 9-oxime erythromycin derivatives
US6407074B1 (en) * 1997-06-11 2002-06-18 Pfizer Inc C-4″-substituted macrolide derivatives
HN1998000074A (es) * 1997-06-11 1999-01-08 Pfizer Prod Inc Derivados de macrolidos c-4 sustituidos
AU7961498A (en) 1997-06-26 1999-01-19 Merck & Co., Inc. 9a-azalides, compositions containing such compounds and methods of treatment
US6339063B1 (en) * 1997-09-10 2002-01-15 Merck & Co., Inc. 9a-azalides as veterinary antimicrobial agents
PA8461401A1 (es) * 1997-10-29 2000-05-24 Pfizer Prod Inc Derivados de eritromicina triciclicos
HN1998000159A (es) * 1997-10-29 1999-02-09 Monsanto Co Derivados de 9- amino - 3 ceto eritromicina
AP1060A (en) 1998-01-02 2002-04-23 Pfizer Prod Inc Novel erythromycin derivatives.
AP9801420A0 (en) 1998-01-02 1998-12-31 Pfizer Prod Inc Novel macrolides.
EP0941998B1 (fr) * 1998-03-03 2004-09-01 Pfizer Products Inc. Antibiotiques macrolides de type 3,6-cétal
WO1999062920A1 (fr) * 1998-06-03 1999-12-09 Pfizer Products Inc. Derives 3-keto tricycliques de 6-o-methylerythromycine
US6043227A (en) * 1998-08-19 2000-03-28 Pfizer Inc. C11 carbamates of macrolide antibacterials
US6100240A (en) * 1998-10-09 2000-08-08 Pfizer Inc Macrolide derivatives
JP4043191B2 (ja) * 1998-11-03 2008-02-06 ファイザー・プロダクツ・インク 新規なマクロライド抗生物質
UA70972C2 (uk) * 1998-11-20 2004-11-15 Пфайзер Продактс Інк. 13-членні азаліди і їх застосування як антибіотиків
EA200100983A1 (ru) 1999-05-24 2002-10-31 Пфайзер Продактс Инк. Производные 13-метилэритромицина
EP1101769A3 (fr) * 1999-11-18 2001-10-24 Pfizer Products Inc. Dérivés de l'érythromycine contenant de l'azote
WO2003014136A1 (fr) 2001-08-08 2003-02-20 Taisho Pharmaceutical Co., Ltd. Composes de 11a-azalide et methode de production de ces composes

Also Published As

Publication number Publication date
UY25574A1 (es) 1999-09-27
UY25330A1 (es) 2000-12-29
GT199800206A (es) 2000-06-21
BG104644A (en) 2001-01-31
PE20000049A1 (es) 2000-02-07
AP9801420A0 (en) 1998-12-31
HUP0100420A3 (en) 2003-07-28
IL137024A0 (en) 2001-06-14
WO1999035156B1 (fr) 1999-10-21
NZ504986A (en) 2003-03-28
DZ2698A1 (fr) 2003-03-29
ZA9811939B (en) 2000-06-30
JP2002500230A (ja) 2002-01-08
WO1999035156A1 (fr) 1999-07-15
AR019787A2 (es) 2002-03-13
CN1284081A (zh) 2001-02-14
CA2316919A1 (fr) 1999-07-15
AR020551A2 (es) 2002-05-15
YU41500A (sh) 2003-02-28
EP1044207A1 (fr) 2000-10-18
AR014948A1 (es) 2001-04-11
AU756409B2 (en) 2003-01-09
OA11438A (en) 2004-04-30
PL341642A1 (en) 2001-04-23
AR020851A2 (es) 2002-05-29
KR20010024818A (ko) 2001-03-26
IS5528A (is) 2000-06-09
US6472371B1 (en) 2002-10-29
AU1444799A (en) 1999-07-26
US7015203B2 (en) 2006-03-21
CA2316919C (fr) 2004-10-26
KR100352809B1 (ko) 2002-11-01
HRP20000442A2 (en) 2001-04-30
MA24729A1 (fr) 1999-07-01
TW520374B (en) 2003-02-11
PA8465301A1 (es) 2000-09-29
BR9814601A (pt) 2000-10-17
CO4970821A1 (es) 2000-11-07
NO20003347D0 (no) 2000-06-27
NO20003347L (no) 2000-08-28
HUP0100420A2 (hu) 2001-07-30
SK9782000A3 (en) 2001-12-03
CZ20002458A3 (cs) 2001-10-17
US20040092459A1 (en) 2004-05-13
EA200000594A1 (ru) 2001-04-23

Similar Documents

Publication Publication Date Title
TNSN98238A1 (fr) Macrolides nouveaux
TNSN98084A1 (fr) Derives de macrolides substitues en position c-4
TNSN98082A1 (fr) DERIVES SUBSTITUES EN C - 4 DE 9 - DESOXO - 9a - aza - 9a HOMOERYTHROMYCINE A.
TNSN00036A1 (fr) Acides oxamiques nouveaux, procede pour leur preparation et compositions pharmaceutiques les contenant.
TNSN99170A1 (fr) Derives de tetrahydroquinoleine substitues nouveaux, procede pour leur preparation et compositions pharmaceutiques les contenant
TNSN98194A1 (fr) Derives nouveaux de 6-o-methylerythromycine a, procede pour leur preparation et compositions pharmaceutiques les contenant
TNSN99162A1 (fr) Derives de quinoleine-2-one a substituant alcynyle nouveaux, procede pour leur preparation et compositions pharmaceutiques les contenant
TNSN99106A1 (fr) Derives d'isothiazole nouveaux, procede pour leur preparation et compositions pharmaceutiques les contenant.
TNSN01091A1 (fr) Derives bicycliques nouveaux, compositions les contenant et leur utilisation pour le traitement d'une croissance cellulaire anormale
TNSN99171A1 (fr) 4-carboxyamino-2-substitue-1,2,3,4-tetrahydroquinoleines, procede pour leur preparation et compositions pharmaceutiques les contenant
TNSN00007A1 (fr) Macrolides nouveaux, procede pour leur preparation et compositions pharmaceutiques les contenant
TNSN99172A1 (fr) 4-carboxyamino-2-methyl-1,2,3,4-tetrahydroquinoleines, procede pour leur preparation et compositions pharmaceutiques les contenant
TNSN99006A1 (fr) 4-(2-ceto-1-benzimidazolinyl) piperidines nouvelles, procede pour leur preparation et compositions pharmaceutiques les contenant
TNSN99156A1 (fr) Derives d'acide hydroxypipecolate-hydroxamique nouveaux, procede pour leur preparation et compositions pharmaceutiques les contenant
TNSN00121A1 (fr) Composes nouveaux inhibiteurs de metalloproteases, procede pour leur preparation et compositions pharmaceutiques les contenant
TNSN00228A1 (fr) Derives de benzimidazole nouveaux, et compositions les contenant
TNSN00028A1 (fr) Derives de quinoleine -2-one a substituant heteroaryle nouveaux procede pour leur preparation et compositions pharmaceutiques les contenant.
TNSN97198A1 (fr) Derives de 6-phenylpyridyl-2- amine et compositions pharmaceutiques les contenant
TNSN97110A1 (fr) Derives de 2-(2-oxo-ethylidene)-imidazolidine-4-one, procede pour leur preparation et compositions pharmaceutiques les contenant
TNSN98017A1 (fr) Derives de sulfonyluree, procede pour leur preparation et compositions pharmaceutiques les contenant.
TNSN99253A1 (fr) Composes chimiques nouveaux modulateurs de ccr5, et compositions pharmaceutiques les contenant.
TNSN99055A1 (fr) Derives bicycliques d'acide hydroxamique nouveaux, procede pour leur preparation et compositions pharmaceutiques les contenant
TNSN01132A1 (fr) Derives de pyrazole nouveaux et compositions les contenant.
TNSN99155A1 (fr) 1-aryl-3-arylmethyl-1,8-naphtyridine-4(1h)-ones nouvelles, procede pour leur preparation et compositions pharmaceutiques les contenant
TNSN00033A1 (fr) Composes nouveaux inhibiteurs de reabsorption de monoamines, procede pour leur preparation, et compositions pharmaceutiques les contenant